Risk factors for childhood obesity in a Greek paediatric population

Dimitrios Papandreou1, Pavlos Malindretos, Israel Rousso

  • 1Second Department of Pediatrics, Aristotle University of Thessaloniki, School of Medicine, Ahepa General Hospital, St. Kiriakidi 1, TK 54636, Greece. papandreoudimitrios@yahoo.gr

Public Health Nutrition
|January 16, 2010
PubMed

Insights

Childhood obesity in Greece is linked to family history, sugary drinks, and TV time. Breastfeeding and physical activity are protective factors against pediatric obesity.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Nutritional Science

Background:

  • Childhood obesity presents a significant public health challenge in Greece.
  • Identifying associated risk factors is crucial for developing effective prevention strategies.

Purpose of the Study:

  • To investigate potential risk factors for pediatric obesity in Greece.
  • Factors examined include birth weight, breastfeeding, dietary habits, family history, and sedentary behaviors.

Main Methods:

  • A case-control study involving 205 overweight/obese children and matched normal-weight controls (aged 7-15 years).
  • Obesity classification followed International Obesity Taskforce criteria.
  • Conditional logistic regression analysis was employed to identify risk factors.

Main Results:

  • Breastfeeding for at least 3 months (OR=0.21) and leisure-time physical activity (OR=0.87) were protective against obesity.
  • Family history of obesity (OR=3.79), sugar-sweetened beverage consumption (OR=1.77), and television viewing (OR=1.99) were significant risk factors.

Conclusions:

  • Findings confirm that shorter breastfeeding duration, family history of obesity, sedentary lifestyle, and sugar-sweetened beverage intake are key risk factors for childhood obesity.
  • Further research is needed to fully understand pediatric obesity predictors and mitigate long-term health consequences.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...